RxDoctor Payments Data

Cody Hoff, PA

Physician Assistant · Grand Rapids, MINPI 1770027344

Payments from drug & device makers

$884in general payments, 2019–2025

Across 38 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sequel Med Tech, LLC$181
  • Dexcom, Inc.$169
  • Novo Nordisk$151
  • Lilly USA, LLC$116
  • Sanofi-aventis U.S. LLC$101
  • Tandem Diabetes Care, Inc.$80
  • plus $87 from 3 others

What the payments were for

  • Food & beverage$884100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$884 in reported general payments places this provider in the 70th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$18,224
Medicare patients
96
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide70$92,494
TrulicityDulaglutide61$72,165
JardianceEmpagliflozin28$43,480
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog23$36,605
OzempicSemaglutide17$27,806
Humalog Kwikpen U-100Insulin Lispro40$19,000
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/719$18,570
Lantus SolostarInsulin Glargine,hum.Rec.Anlog65$13,844
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$12,939
HumalogInsulin Lispro24$11,278
Novolog FlexpenInsulin Aspart12$9,908
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$4,491
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic16$2,361
Nano 2nd Gen Pen NeedlePen Needle, Diabetic17$1,970
Ulticare Pen NeedlePen Needle, Diabetic11$1,867

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$116$175,937155 claims
Boehringer IngelheimJardiance$46$43,48028 claims
Novo NordiskOzempic$151$27,80617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →